TLSI
TriSalus Life Sciences Inc.
NASDAQ: TLSI · HEALTHCARE · MEDICAL DEVICES
$4.39
+1.62% today
Updated 2026-05-01
Market cap
$275.75M
P/E ratio
—
P/S ratio
6.11x
EPS (TTM)
$-1.84
Dividend yield
—
52W range
$3 – $8
Volume
0.2M
TriSalus Life Sciences Inc. (TLSI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-86.90%
Operating margin
-24.80%
ROE
-496.20%
ROA
-56.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $8.40M | $-28.84M | 85.80% | -286.06% | -343.35% |
| 2022 | $12.40M | $-47.19M | 81.79% | -293.91% | -380.60% |
| 2023 | $18.51M | $-59.36M | 85.93% | -294.28% | -320.69% |
| 2024 | $29.43M | $-33.23M | 86.06% | -122.88% | -112.92% |
| 2025 | $45.15M | $-39.23M | 84.57% | -59.68% | -86.88% |